Developer docs
API playgroundTry for free, no card

Search company profiles

LIFE AI

Full company profile

uuid003t9z1

Namestring
LIFE AI
Legal namestring
LIFE AI Foundation
Websiteurl
lifenetwork.ai
Company typeenum
Private
Founded yearint
2017
Descriptiontext

LIFE AI (legally LIFE AI Foundation) is a Singapore-incorporated non-profit founded in 2017 by Dr. Tuan Cao, a former Google engineering leader. It operates an AI-native blockchain platform for decentralized science in genomics and precision health, anchored by its Biohub infrastructure layer. The Biohub coordinates real-world health data, AI-driven pattern recognition, and human participation through a modular subnet architecture that includes Genetica (genetic testing), PREVANA (preventive healthcare), Life Cloud (infrastructure), Life Unity (community governance), and InfiniteLife (longevity). Data sovereignty is enforced via blockchain-based Gene NFTs secured by Trusted Execution Environments, and the platform processes 15+ petabytes of health intelligence drawn from 550,000+ human contributors and 110,000+ verified identities across 7 countries (U.S., Korea, Hong Kong, Singapore, Indonesia, Thailand, Vietnam).

The company serves three distinct customer segments. Pharmaceutical and biotech firms such as Kalbe Farma (Southeast Asia's largest pharmaceutical company) use the platform for co-development of precision-health products, with the StrokeGENME partnership delivering a documented 24→6 week development compression. Research institutions and hospitals, including Hue Central Hospital and Stanford, Cornell, and UCSF, leverage the platform's large-scale genetic-study infrastructure. Individual consumers access genetic testing, preventive-health services, and personalized recommendations through the LIFE App super app, supported by 100,000+ paid users.

Revenue is generated through a hybrid model that includes genetic testing service fees, enterprise co-development and licensing agreements with pharmaceutical partners, research infrastructure fees, distribution commissions from partner mini-apps operating on the platform, and an emerging AI-first Model-as-a-Service offering validated through the NVIDIA-backed FastTrack AI Accelerator. Strategic partnerships span NVIDIA, GenAI Fund, SOL Corporation International, and Stanford/Cornell/UCSF research collaborations. Total funding raised is approximately $12M, headcount is 51-100, and the company claims $8.65B in coordinated innovation value across 100+ partners.

Short descriptiontext

LIFE AI Foundation operates the Biohub, an AI-native blockchain infrastructure layer for decentralized genomics and precision health. It coordinates 15+ petabytes of real-world health data from 550,000+ contributors across 7 countries, serving pharmaceutical firms, research institutions, and individual consumers through modular subnets including Genetica, PREVANA, and InfiniteLife.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersSingapore, Singapore
HQ citystring
Singapore
HQ countrystring
Singapore
HQ regionstring
Asia
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
precision health platform, decentralized genomics infrastructure, AI health data platform, blockchain health data sovereignty, real-world health analytics
Industry4 codes
PRIMARYHLAGAJAO
AI/ML Platforms for Drug Discovery & Experiment Optimization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAD
Bioinformatics & Multi-omics Analysis Software
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAC
Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHDAEANAA
End-to-End Enterprise AI Platforms (MLOps & Model Lifecycle Management)
Hardware, Technology & Telecom/Enterprise Platforms & Databases/Artificial Intelligence Platforms for Enterprise
NAICS code3 codes
  • Software Publishers51321
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services518210
SIC code2 codes
  • Services-Commercial Physical & Biological Research8731
  • Services-Prepackaged Software7372
Product category
Healthcare AI Infrastructure
Social media profiles1 record
GTM motion5 records

Each record includes

Type, Description, Source

Revenue model5 records
1Precision Health Subscription Services
TypeSubscription Recurring
Description

The LIFE App serves as a super app platform enabling users to access genetic testing services, personalized health recommendations, and community health features. The platform powers precision health services for 100,000+ paid users across seven countries. VIP membership is earned through activity (purchasing 3 genetic testing packages), entitling members to a 30% discount on subsequent tests. Revenue is derived from genetic testing service fees (new packages for first-time users, unlock packages for existing users expanding analyzed genetic data). All testing is performed by licensed partners such as Genetica.

lifenetwork.ai
2Pharmaceutical & Biotech Partnership Revenue
TypeLicensing Royalties
Description

LIFE AI provides its Biohub infrastructure to pharmaceutical and biotech companies for developing precision health products. Kalbe Farma launched StrokeGENME (personalized stroke prevention) using LIFE AI's platform, demonstrating 10x–30x reduction in development costs. Revenue generated through co-development agreements, platform licensing fees, and outcome-based arrangements with pharma partners.

lifenetwork.ai
3Research Infrastructure & Platform Licensing
TypeProfessional Services
Description

Research institutions and pharmaceutical companies access the Biohub infrastructure to compress validation timelines and reduce research costs. Hue Central Hospital conducted Southeast Asia's largest autism genetics study on the platform for $10K vs. an estimated $1M+. Revenue generated through research collaboration agreements and platform access fees.

lifenetwork.ai
4Distribution Revenue (Partner Mini-Apps)
TypeMarketplace Commission
Description

The LIFE App integrates multiple independently operated partner mini-applications. Partners reach engaged health-conscious users through the Human Health Network. LIFE AI generates revenue through distribution partnership fees and revenue-sharing arrangements with product and enterprise teams deploying on the platform.

lifenetwork.ai
5AI-First Model-as-a-Service (MaaS)
TypeSubscription Recurring
Description

LIFE AI is transitioning from a traditional model to an AI-first 'Model-as-a-Service' strategy, providing AI compute infrastructure, models, and APIs to enterprise partners for launching life-science products. Supported by GPU resources and technical support from NVIDIA through the FastTrack AI Accelerator program.

lifenetwork.ai
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels6 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Technology or R&D, Personnel, Marketing or Sales, Operations
Pricing details3 tiers
1Entry-level membership with basic platform access at no cost
ModelFreemiumBilling cadenceMonthly
Notes

Regular Members can access basic services including account creation, limited educational resources, community engagement, and select essential functions. No purchase required.

lifenetwork.ai
2Earned through purchasing three genetic testing packages (New or Unlock Packages)
ModelHybridBilling cadenceMulti-year contract
Notes

VIP Members are entitled to a 30% discount for subsequent genetic testing services. No upfront or recurring membership fee. VIP status is managed automatically based on verified service transactions (3 genetic testing package purchases). If VIP expires, commitments freeze and resume upon renewal.

lifenetwork.ai
3Genetic Testing Services via licensed partners (Genetica)
ModelUnit PricingBilling cadencePay-as-you-go
Notes

New Packages: first-time users of Genetic Testing Services. Unlock Packages: existing users who wish to expand previously analyzed genetic data. VIP Members receive 30% discount on subsequent testing services. All testing and analysis performed by authorized laboratories.

lifenetwork.ai
GTM typeB2B and B2C
B2B and B2C
Offering typeSoftware
Software
Brand1 of 7 records shown
1Biohub
Description

The infrastructure layer for human health that integrates AI capabilities, biotech innovation, and human participation in one infrastructure layer.

lifenetwork.ai
+6 more records
Core offering1 text field

LIFE AI operates the Biohub, an AI-native infrastructure layer that integrates real-world health dynamics, biotech innovation, and human participation. The platform aggregates 15+ petabytes of health intelligence from 550,000+ humans, enables blockchain-secured data sovereignty via Gene NFTs, and provides pharmaceutical companies, hospitals, and researchers with infrastructure to compress healthcare product development cycles. Consumer-facing access is delivered through the LIFE App super app, which integrates genetic testing services, personalized health insights, and partner mini-applications.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 8 values shown
  • Healthcare product development compressed from 24 months to 6 weeks (16x faster)
+7 more records
Product overview1 text field

LIFE AI operates a foundational AI-native platform built around the Biohub infrastructure layer, which integrates AI capabilities, biotech innovation, and human participation to coordinate real-world health dynamics. The platform is structured as a platform-plus-modules architecture, with the core Biohub coordinating four key subnets: Genetica (genetic testing and personalized health analysis), Prevana (preventive healthcare subnets deployed nationally), Life Cloud (cloud infrastructure), and InfiniteLife (longevity focus). Community engagement is handled through Life Unity with its PoL contribution-recognition mechanism, while Life Points (LP) serve as internal reward tokens. The LIFE App super app sits at the user-facing layer, integrating partner-operated mini applications. The company serves 100,000+ paid users across seven countries and has demonstrated infrastructure-level impact through products like StrokeGENME (co-developed with Kalbe Farma), which compressed a typical 24-month development cycle into 6 weeks.

Product and service8 records
1Biohub
CategoryCore Platform / Infrastructure
Description

The foundational AI-native infrastructure layer of LIFE AI, integrating AI capabilities, biotech innovation, and human participation to coordinate real-world health dynamics across 550,000+ humans, 15+ petabytes of health data, and 110,000+ verified identities. Serves as the coordination layer for capital allocators, research institutions, pharmaceutical companies, and product teams building precision health applications.

2LIFE App
3Genetica
4Prevana
CategoryPreventive Healthcare Subnet
Description

A preventive healthcare subnet within the Biohub ecosystem, deployed nationally in Thailand as the first large-scale validation environment. Delivers AI-enabled health insights integrated with community health infrastructure to shift healthcare from reactive treatment toward continuous, preventive lifecare.

5Life Cloud
6Life Unity
7InfiniteLife
8StrokeGENME
CategoryPrecision Health Application
Description

A genetics-powered platform co-developed with Kalbe Farma that translates DNA insights into individualized stroke-prevention plans, delivered through Kalbe's nationwide ecosystem across Indonesia. Achieved a 10x-30x reduction in development costs and compressed development from 24 months to 6 weeks compared to traditional approaches.

Scale indicator13 records

Each record includes

Type, Value, Description, Source

Partnership14 partners
1New Turing Institute
Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2026-05-29
Description

New Turing Institute co-organized the GStar Summit 2026 (human-centered AI conference in Ho Chi Minh City, Vietnam) alongside Pacific Gateway Partners. The summit attracted over 1,000 participants from 160+ companies and institutions, with speakers from Google DeepMind, NVIDIA, Meta, and SK Group. The event marked Vietnam's growing strategic role in the Asia-Pacific AI landscape.

en.vneconomy.vn
Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2026-05-29
Description

Pacific Gateway Partners co-organized the GStar Summit 2026 alongside the New Turing Institute. The summit positioned Vietnam as a growing strategic hub in the Asia-Pacific AI landscape and reinforced LIFE AI's presence in the regional AI ecosystem.

3Volunteer Medical Association (Thailand)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-12
Description

Thailand's largest medical volunteer organization partnered with LIFE AI for the nationwide deployment of the PREVANA subnet. VMA's nationwide network of volunteer healthcare providers enables PREVANA to reach Thai communities across urban centers and remote areas, extending the Biohub's infrastructure reach at unprecedented scale through trusted human presence in the preventative lifecare journey.

lifenetwork.ai
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-10-27
Description

LIFE AI participates in the NVIDIA Inception Program as part of the FastTrack AI Accelerator. NVIDIA provides GPU resources, technical support from NVIDIA experts, and cloud provider infrastructure. Life AI's Parkinson's drug discovery platform was accelerated by 40% through AI-driven in-silico design using NVIDIA infrastructure. The partnership validates LIFE AI's technical infrastructure capabilities.

5SOL Corporation International
Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2024-11-29
Description

LIFE AI signed a strategic partnership agreement with SOL Corporation International, a prominent healthcare company in Asia. SOL Corporation aims to bring protective and healthcare solutions developed with Nano Gold technology to the people of Asia. SOL views LIFE AI as a key enabler for traditional Web2 companies to transition into the Web3 ecosystem, expanding customer reach and delivering tailored services with unprecedented precision.

lifenetwork.ai
Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Kalbe Farma, Southeast Asia's largest publicly listed pharmaceutical company, partnered with LIFE AI to launch StrokeGENME — a genetics-powered platform translating DNA insights into individualized stroke-prevention plans delivered through Kalbe's nationwide ecosystem. Development was compressed from 24 months to 6 weeks at 10x–30x lower cost. Kalbe serves millions through its extensive network in medicine, diagnostics, and clinical services across Indonesia. The partnership represents LIFE AI's flagship enterprise commercial reference.

7Hue Central Hospital
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Hue Central Hospital conducted Southeast Asia's largest autism genetics study (5,000 patients) on LIFE AI infrastructure for $10K instead of an estimated $250K+. The study was published in a top-tier peer-reviewed journal at 25x lower cost than traditional research pathways. This partnership demonstrates the Biohub's ability to enable large-scale clinical research at dramatically reduced cost.

lifenetwork.ai
Strategic tierCoreTypeStrategic or Co-development Partner
Description

LIFE AI maintains research collaborations with scientists from Stanford, Cornell, and UCSF. The company was founded by engineers and scientists from Cornell University, UC Berkeley, and UCSF. These academic partnerships support research validation, scientific rigor, and peer-reviewed publication of research conducted on the Biohub infrastructure.

Strategic tierStrategicTypeStrategic or Co-development Partner
Description

Google served as a strategic partner for GStar Summit 2026, a human-centered AI conference in Ho Chi Minh City, Vietnam. The summit featured executives from Google DeepMind among 20 world-class speakers discussing agentic AI, education in the AI era, and AI applications across industries.

10FPT
Strategic tierStrategicTypeStrategic or Co-development Partner
Description

FPT served as a strategic partner for GStar Summit 2026 alongside Google. FPT is a major Vietnamese technology corporation and one of Vietnam's leading AI players, contributing to discussions on AI applications across industries in the Asia-Pacific region.

en.vneconomy.vn
Strategic tierMinorTypeOthers
Description

Grab was listed as a supporter for GStar Summit 2026 alongside LIFE AI, Vietnam Airlines, Calif, Galaxy Holdings, and VNG. The summit marked Vietnam's growing strategic role in the Asia-Pacific AI landscape.

12VNG
Strategic tierMinorTypeOthers
Description

VNG was listed as a supporter for GStar Summit 2026 alongside LIFE AI, Grab, Vietnam Airlines, Calif, and Galaxy Holdings. VNG is a leading Vietnamese technology company.

en.vneconomy.vn
Strategic tierCoreTypeTechnology or Integration
Description

Genetica is a licensed partner providing genetic testing services through the LIFE AI platform. LIFE AI facilitates user access to genetic testing and personalized health analysis through Genetica. Genetica created Southeast Asia's largest native genetic dataset with over 99% decoding accuracy and has provided over 2 million personalized health recommendations. Genetica is a subnet within the Biohub ecosystem.

14Blockchange
Strategic tierMinorTypeOthers
Description

Listed as a partner logo alongside Kalbe Farma, ParaFi, and Avalanche on the LIFE AI Biohub homepage under partner/ecosystem section.

lifenetwork.ai
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1iCarbonX
TypeEmerging player
Description

iCarbonX combines multi-omics, AI, and consumer health data to build digital health profiles and partner with pharma on precision medicine. Comparable to LIFE AI's integration of multi-omics, lifestyle, and outcomes data for AI-driven health insights, though focused on a Chinese consumer ecosystem.

TypeEmerging player
Description

Medable provides a decentralized clinical trial platform that connects sponsors, sites, and patients for faster, more representative studies. Comparable to LIFE AI's Biohub in enabling clinical and real-world research at lower cost and faster timelines, though focused specifically on trial execution rather than genomic infrastructure.

TypeEmerging player
Description

Nebula Genomics offers decentralized, blockchain-based whole-genome sequencing with user data ownership and privacy protections. Directly comparable to LIFE AI's Gene NFT and blockchain data sovereignty model in the Web3/decentralized genomics niche, though Nebula is significantly smaller and less integrated with pharma and research workflows.

TypeBroad incumbent
Description

23andMe is a consumer genomics platform with one of the largest direct-to-consumer genetic databases globally, used historically for ancestry, trait, and health risk insights. Comparable to LIFE AI's consumer genomics + research data approach, though 23andMe is a Western incumbent that LIFE AI explicitly positions its decentralized model against.

TypeBroad incumbent
Description

Verily is Alphabet's life sciences and precision health subsidiary building data platforms, devices, and clinical research infrastructure. Comparable to LIFE AI at the layer of integrated health data infrastructure and clinical research enablement, but as a much larger, broader incumbent with deeper capital and Western market focus.

6Tempus AI
TypeDirect peer
Description

Tempus AI builds an AI-powered precision medicine platform that aggregates molecular and clinical data at scale to enable pharma R&D and clinical decision support. Highly comparable to LIFE AI's Biohub model of using integrated real-world biological data plus AI tooling to accelerate pharma and clinical workflows, though Tempus is more oncology-focused and operates in Western markets.

TypeDirect peer
Description

Owkin uses federated AI on real-world patient data to accelerate drug discovery and clinical research for biopharma partners. Comparable to LIFE AI's approach of combining AI with real-world health dynamics and pharma partnerships, though Owkin is Europe-focused and emphasizes federated learning.

TypeDirect peer
Description

SOPHiA Genetics operates an AI-driven genomics and multimodal data platform used by hospitals and research institutions to standardize and interpret complex genomic and phenotypic data. Closely mirrors LIFE AI's positioning as AI-powered infrastructure that compresses research timelines and enables precision health for hospital and research partners globally.

TypeDirect peer
Description

DNAnexus provides a cloud-based biomedical data analysis and management platform used by pharma, biotech, and clinical labs to process genomic and multi-omics data. Directly comparable to LIFE AI's Biohub as a shared infrastructure layer for sequencing, bioinformatics, and clinical research workflows, with similar enterprise R&D customer base.

TypeOthers
Description

Avalanche is a blockchain platform used by LIFE AI's ecosystem partners and referenced in the Biohub partner ecosystem. Listed as a relevant adjacent enabling technology for LIFE AI's Gene NFT and decentralized infrastructure, rather than a direct competitor.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability9 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

LIFE AI

Healthcare AI Infrastructurelifenetwork.ai

LIFE AI Foundation operates the Biohub, an AI-native blockchain infrastructure layer for decentralized genomics and precision health. It coordinates 15+ petabytes of real-world health data from 550,000+ contributors across 7 countries, serving pharmaceutical firms, research institutions, and individual consumers through modular subnets including Genetica, PREVANA, and InfiniteLife.

What LIFE AI does

LIFE AI (legally LIFE AI Foundation) is a Singapore-incorporated non-profit founded in 2017 by Dr. Tuan Cao, a former Google engineering leader. It operates an AI-native blockchain platform for decentralized science in genomics and precision health, anchored by its Biohub infrastructure layer. The Biohub coordinates real-world health data, AI-driven pattern recognition, and human participation through a modular subnet architecture that includes Genetica (genetic testing), PREVANA (preventive healthcare), Life Cloud (infrastructure), Life Unity (community governance), and InfiniteLife (longevity). Data sovereignty is enforced via blockchain-based Gene NFTs secured by Trusted Execution Environments, and the platform processes 15+ petabytes of health intelligence drawn from 550,000+ human contributors and 110,000+ verified identities across 7 countries (U.S., Korea, Hong Kong, Singapore, Indonesia, Thailand, Vietnam).

The company serves three distinct customer segments. Pharmaceutical and biotech firms such as Kalbe Farma (Southeast Asia's largest pharmaceutical company) use the platform for co-development of precision-health products, with the StrokeGENME partnership delivering a documented 24→6 week development compression. Research institutions and hospitals, including Hue Central Hospital and Stanford, Cornell, and UCSF, leverage the platform's large-scale genetic-study infrastructure. Individual consumers access genetic testing, preventive-health services, and personalized recommendations through the LIFE App super app, supported by 100,000+ paid users.

Revenue is generated through a hybrid model that includes genetic testing service fees, enterprise co-development and licensing agreements with pharmaceutical partners, research infrastructure fees, distribution commissions from partner mini-apps operating on the platform, and an emerging AI-first Model-as-a-Service offering validated through the NVIDIA-backed FastTrack AI Accelerator. Strategic partnerships span NVIDIA, GenAI Fund, SOL Corporation International, and Stanford/Cornell/UCSF research collaborations. Total funding raised is approximately $12M, headcount is 51-100, and the company claims $8.65B in coordinated innovation value across 100+ partners.

LIFE AI firmographics

Firmographics
Name
LIFE AI
Legal name
LIFE AI Foundation
Website
https://lifenetwork.ai
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
51–100 employees
Short description
LIFE AI Foundation operates the Biohub, an AI-native blockchain infrastructure layer for decentralized genomics and precision health. It coordinates 15+ petabytes of real-world health data from 550,000+ contributors across 7 countries, serving pharmaceutical firms, research institutions, and individual consumers through modular subnets including Genetica, PREVANA, and InfiniteLife.
Ownership category
akta.pro rank

LIFE AI industry classification

Industry
Product category
Healthcare AI Infrastructure
NAICS
Software Publishers (51321), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (518210)
SIC
Services-Commercial Physical & Biological Research (8731), Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYHLAGAJAO
AI/ML Platforms for Drug Discovery & Experiment Optimization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAD
Bioinformatics & Multi-omics Analysis Software
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAC
Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHDAEANAA
End-to-End Enterprise AI Platforms (MLOps & Model Lifecycle Management)
Hardware, Technology & Telecom/Enterprise Platforms & Databases/Artificial Intelligence Platforms for Enterprise

Keywords

  • Precision health platform
  • Decentralized genomics infrastructure
  • AI health data platform
  • Blockchain health data sovereignty
  • Real-world health analytics

Where LIFE AI is headquartered

Location

Headquarters

HQ city
Singapore
HQ country
Singapore
HQ region
Asia

Offices2 records

Markets served

LIFE AI business model

Business model
GTM type
B2B and B2C
Offering type
Software
Cost components
Technology or R&D, Personnel, Marketing or Sales, Operations

Revenue model

  1. Precision Health Subscription Services: The LIFE App serves as a super app platform enabling users to access genetic testing services, personalized health recommendations, and community health features. The platform powers precision health services for 100,000+ paid users across seven countries. VIP membership is earned through activity (purchasing 3 genetic testing packages), entitling members to a 30% discount on subsequent tests. Revenue is derived from genetic testing service fees (new packages for first-time users, unlock packages for existing users expanding analyzed genetic data). All testing is performed by licensed partners such as Genetica.
  2. Pharmaceutical & Biotech Partnership Revenue: LIFE AI provides its Biohub infrastructure to pharmaceutical and biotech companies for developing precision health products. Kalbe Farma launched StrokeGENME (personalized stroke prevention) using LIFE AI's platform, demonstrating 10x–30x reduction in development costs. Revenue generated through co-development agreements, platform licensing fees, and outcome-based arrangements with pharma partners.
  3. Research Infrastructure & Platform Licensing: Research institutions and pharmaceutical companies access the Biohub infrastructure to compress validation timelines and reduce research costs. Hue Central Hospital conducted Southeast Asia's largest autism genetics study on the platform for $10K vs. an estimated $1M+. Revenue generated through research collaboration agreements and platform access fees.
  4. Distribution Revenue (Partner Mini-Apps): The LIFE App integrates multiple independently operated partner mini-applications. Partners reach engaged health-conscious users through the Human Health Network. LIFE AI generates revenue through distribution partnership fees and revenue-sharing arrangements with product and enterprise teams deploying on the platform.
  5. AI-First Model-as-a-Service (MaaS): LIFE AI is transitioning from a traditional model to an AI-first 'Model-as-a-Service' strategy, providing AI compute infrastructure, models, and APIs to enterprise partners for launching life-science products. Supported by GPU resources and technical support from NVIDIA through the FastTrack AI Accelerator program.

Pricing tiers

ModelBillingPrice
FreemiumMonthlyEntry-level membership with basic platform access at no cost
HybridMulti-year contractEarned through purchasing three genetic testing packages (New or Unlock Packages)
Unit PricingPay-as-you-goGenetic Testing Services via licensed partners (Genetica)

Go-to-market motion5 records

Distribution channels6 records

Marketing channels6 records

LIFE AI product offering

Product offering

Core offering

LIFE AI operates the Biohub, an AI-native infrastructure layer that integrates real-world health dynamics, biotech innovation, and human participation. The platform aggregates 15+ petabytes of health intelligence from 550,000+ humans, enables blockchain-secured data sovereignty via Gene NFTs, and provides pharmaceutical companies, hospitals, and researchers with infrastructure to compress healthcare product development cycles. Consumer-facing access is delivered through the LIFE App super app, which integrates genetic testing services, personalized health insights, and partner mini-applications.

Product overview

LIFE AI operates a foundational AI-native platform built around the Biohub infrastructure layer, which integrates AI capabilities, biotech innovation, and human participation to coordinate real-world health dynamics. The platform is structured as a platform-plus-modules architecture, with the core Biohub coordinating four key subnets: Genetica (genetic testing and personalized health analysis), Prevana (preventive healthcare subnets deployed nationally), Life Cloud (cloud infrastructure), and InfiniteLife (longevity focus). Community engagement is handled through Life Unity with its PoL contribution-recognition mechanism, while Life Points (LP) serve as internal reward tokens. The LIFE App super app sits at the user-facing layer, integrating partner-operated mini applications. The company serves 100,000+ paid users across seven countries and has demonstrated infrastructure-level impact through products like StrokeGENME (co-developed with Kalbe Farma), which compressed a typical 24-month development cycle into 6 weeks.

Differentiator

Problem solved

Functional benefit

Brands

  • Biohub: The infrastructure layer for human health that integrates AI capabilities, biotech innovation, and human participation in one infrastructure layer.
  • Genetica
  • PREVANA
  • InfiniteLife
  • Life Unity
  • Life Cloud
  • StrokeGENME

Products and services

  • Biohub The foundational AI-native infrastructure layer of LIFE AI, integrating AI capabilities, biotech innovation, and human participation to coordinate real-world health dynamics across 550,000+ humans, 15+ petabytes of health data, and 110,000+ verified identities. Serves as the coordination layer for capital allocators, research institutions, pharmaceutical companies, and product teams building precision health applications.
  • LIFE App
  • Genetica
  • Prevana A preventive healthcare subnet within the Biohub ecosystem, deployed nationally in Thailand as the first large-scale validation environment. Delivers AI-enabled health insights integrated with community health infrastructure to shift healthcare from reactive treatment toward continuous, preventive lifecare.
  • Life Cloud
  • Life Unity
  • InfiniteLife
  • StrokeGENME A genetics-powered platform co-developed with Kalbe Farma that translates DNA insights into individualized stroke-prevention plans, delivered through Kalbe's nationwide ecosystem across Indonesia. Achieved a 10x-30x reduction in development costs and compressed development from 24 months to 6 weeks compared to traditional approaches.

Quantifiable outcome

  • Healthcare product development compressed from 24 months to 6 weeks (16x faster)
  • +7 more outcomes

Companies that use LIFE AI

Customer profile

Named customers6 records

Segments4 records

Ideal customer profiles4 records

LIFE AI technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability9 records

Feature7 records

LIFE AI partnerships and signals

Strategic signal

Partnerships

14 partnerships are on record, tiered major, core, flagship, strategic and minor.

  • New Turing InstitutemajorStrategic or Co-development Partner · 29 May 2026New Turing Institute co-organized the GStar Summit 2026 (human-centered AI conference in Ho Chi Minh City, Vietnam) alongside Pacific Gateway Partners. The summit attracted over 1,000 participants from 160+ companies and institutions, with speakers from Google DeepMind, NVIDIA, Meta, and SK Group. The event marked Vietnam's growing strategic role in the Asia-Pacific AI landscape.
  • Pacific Gateway PartnersmajorStrategic or Co-development Partner · 29 May 2026Pacific Gateway Partners co-organized the GStar Summit 2026 alongside the New Turing Institute. The summit positioned Vietnam as a growing strategic hub in the Asia-Pacific AI landscape and reinforced LIFE AI's presence in the regional AI ecosystem.
  • Volunteer Medical Association (Thailand)coreStrategic or Co-development Partner · 12 January 2026Thailand's largest medical volunteer organization partnered with LIFE AI for the nationwide deployment of the PREVANA subnet. VMA's nationwide network of volunteer healthcare providers enables PREVANA to reach Thai communities across urban centers and remote areas, extending the Biohub's infrastructure reach at unprecedented scale through trusted human presence in the preventative lifecare journey.
  • NVIDIA Inception ProgramcoreTechnology or Integration · 27 October 2025LIFE AI participates in the NVIDIA Inception Program as part of the FastTrack AI Accelerator. NVIDIA provides GPU resources, technical support from NVIDIA experts, and cloud provider infrastructure. Life AI's Parkinson's drug discovery platform was accelerated by 40% through AI-driven in-silico design using NVIDIA infrastructure. The partnership validates LIFE AI's technical infrastructure capabilities.
  • SOL Corporation InternationalmajorStrategic or Co-development Partner · 29 November 2024LIFE AI signed a strategic partnership agreement with SOL Corporation International, a prominent healthcare company in Asia. SOL Corporation aims to bring protective and healthcare solutions developed with Nano Gold technology to the people of Asia. SOL views LIFE AI as a key enabler for traditional Web2 companies to transition into the Web3 ecosystem, expanding customer reach and delivering tailored services with unprecedented precision.
  • Kalbe Farma (PT Kalbe Farma Tbk)flagshipStrategic or Co-development PartnerKalbe Farma, Southeast Asia's largest publicly listed pharmaceutical company, partnered with LIFE AI to launch StrokeGENME — a genetics-powered platform translating DNA insights into individualized stroke-prevention plans delivered through Kalbe's nationwide ecosystem. Development was compressed from 24 months to 6 weeks at 10x–30x lower cost. Kalbe serves millions through its extensive network in medicine, diagnostics, and clinical services across Indonesia. The partnership represents LIFE AI's flagship enterprise commercial reference.
  • Hue Central HospitalcoreStrategic or Co-development PartnerHue Central Hospital conducted Southeast Asia's largest autism genetics study (5,000 patients) on LIFE AI infrastructure for $10K instead of an estimated $250K+. The study was published in a top-tier peer-reviewed journal at 25x lower cost than traditional research pathways. This partnership demonstrates the Biohub's ability to enable large-scale clinical research at dramatically reduced cost.
  • Stanford University, Cornell University, UCSFcoreStrategic or Co-development PartnerLIFE AI maintains research collaborations with scientists from Stanford, Cornell, and UCSF. The company was founded by engineers and scientists from Cornell University, UC Berkeley, and UCSF. These academic partnerships support research validation, scientific rigor, and peer-reviewed publication of research conducted on the Biohub infrastructure.
  • GooglestrategicStrategic or Co-development PartnerGoogle served as a strategic partner for GStar Summit 2026, a human-centered AI conference in Ho Chi Minh City, Vietnam. The summit featured executives from Google DeepMind among 20 world-class speakers discussing agentic AI, education in the AI era, and AI applications across industries.
  • FPTstrategicStrategic or Co-development PartnerFPT served as a strategic partner for GStar Summit 2026 alongside Google. FPT is a major Vietnamese technology corporation and one of Vietnam's leading AI players, contributing to discussions on AI applications across industries in the Asia-Pacific region.
  • GrabminorOthersGrab was listed as a supporter for GStar Summit 2026 alongside LIFE AI, Vietnam Airlines, Calif, Galaxy Holdings, and VNG. The summit marked Vietnam's growing strategic role in the Asia-Pacific AI landscape.
  • VNGminorOthersVNG was listed as a supporter for GStar Summit 2026 alongside LIFE AI, Grab, Vietnam Airlines, Calif, and Galaxy Holdings. VNG is a leading Vietnamese technology company.
  • GeneticacoreTechnology or IntegrationGenetica is a licensed partner providing genetic testing services through the LIFE AI platform. LIFE AI facilitates user access to genetic testing and personalized health analysis through Genetica. Genetica created Southeast Asia's largest native genetic dataset with over 99% decoding accuracy and has provided over 2 million personalized health recommendations. Genetica is a subnet within the Biohub ecosystem.
  • BlockchangeminorOthersListed as a partner logo alongside Kalbe Farma, ParaFi, and Avalanche on the LIFE AI Biohub homepage under partner/ecosystem section.

Scale indicators13 records

Recent moves7 records

Expansion highlights6 records

LIFE AI competitors and assessment

Company assessment

Emerging players

  • iCarbonX: iCarbonX combines multi-omics, AI, and consumer health data to build digital health profiles and partner with pharma on precision medicine. Comparable to LIFE AI's integration of multi-omics, lifestyle, and outcomes data for AI-driven health insights, though focused on a Chinese consumer ecosystem.
  • Medable: Medable provides a decentralized clinical trial platform that connects sponsors, sites, and patients for faster, more representative studies. Comparable to LIFE AI's Biohub in enabling clinical and real-world research at lower cost and faster timelines, though focused specifically on trial execution rather than genomic infrastructure.
  • Nebula Genomics: Nebula Genomics offers decentralized, blockchain-based whole-genome sequencing with user data ownership and privacy protections. Directly comparable to LIFE AI's Gene NFT and blockchain data sovereignty model in the Web3/decentralized genomics niche, though Nebula is significantly smaller and less integrated with pharma and research workflows.

Broad incumbents

  • 23andMe: 23andMe is a consumer genomics platform with one of the largest direct-to-consumer genetic databases globally, used historically for ancestry, trait, and health risk insights. Comparable to LIFE AI's consumer genomics + research data approach, though 23andMe is a Western incumbent that LIFE AI explicitly positions its decentralized model against.
  • Verily (Alphabet): Verily is Alphabet's life sciences and precision health subsidiary building data platforms, devices, and clinical research infrastructure. Comparable to LIFE AI at the layer of integrated health data infrastructure and clinical research enablement, but as a much larger, broader incumbent with deeper capital and Western market focus.

Direct peers

  • Tempus AI: Tempus AI builds an AI-powered precision medicine platform that aggregates molecular and clinical data at scale to enable pharma R&D and clinical decision support. Highly comparable to LIFE AI's Biohub model of using integrated real-world biological data plus AI tooling to accelerate pharma and clinical workflows, though Tempus is more oncology-focused and operates in Western markets.
  • Owkin: Owkin uses federated AI on real-world patient data to accelerate drug discovery and clinical research for biopharma partners. Comparable to LIFE AI's approach of combining AI with real-world health dynamics and pharma partnerships, though Owkin is Europe-focused and emphasizes federated learning.
  • SOPHiA Genetics: SOPHiA Genetics operates an AI-driven genomics and multimodal data platform used by hospitals and research institutions to standardize and interpret complex genomic and phenotypic data. Closely mirrors LIFE AI's positioning as AI-powered infrastructure that compresses research timelines and enables precision health for hospital and research partners globally.
  • DNAnexus: DNAnexus provides a cloud-based biomedical data analysis and management platform used by pharma, biotech, and clinical labs to process genomic and multi-omics data. Directly comparable to LIFE AI's Biohub as a shared infrastructure layer for sequencing, bioinformatics, and clinical research workflows, with similar enterprise R&D customer base.

Others

  • Avalanche (blockchain infrastructure): Avalanche is a blockchain platform used by LIFE AI's ecosystem partners and referenced in the Biohub partner ecosystem. Listed as a relevant adjacent enabling technology for LIFE AI's Gene NFT and decentralized infrastructure, rather than a direct competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

LIFE AI social profiles

Digital presence

LIFE AI compliance and trust

Trust signal

Compliance3 records

LIFE AI financial estimates

Financial estimate

Revenue estimate

Valuation estimate

LIFE AI leadership team

Management profile

Number of profiles

Profiles1 record

LIFE AI funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

LIFE AI M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about LIFE AI

What does LIFE AI do?

LIFE AI operates the Biohub, an AI-native infrastructure layer that integrates real-world health dynamics, biotech innovation, and human participation. The platform aggregates 15+ petabytes of health intelligence from 550,000+ humans, enables blockchain-secured data sovereignty via Gene NFTs, and provides pharmaceutical companies, hospitals, and researchers with infrastructure to compress healthcare product development cycles. Consumer-facing access is delivered through the LIFE App super app, which integrates genetic testing services, personalized health insights, and partner mini-applications.

Is LIFE AI a public or private company?

LIFE AI is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was LIFE AI founded?

LIFE AI was founded in 2017. It employs 51 to 100 people.

Where is LIFE AI based?

LIFE AI is headquartered in Singapore, Singapore, in the Asia region.

How does LIFE AI make money?

Five revenue lines are on record. Precision Health Subscription Services are the primary driver. The others are pharmaceutical & Biotech Partnership Revenue, research Infrastructure & Platform Licensing, distribution Revenue (Partner Mini-Apps) and AI-First Model-as-a-Service (MaaS).

Who are LIFE AI's main competitors?

Emerging players on record are iCarbonX, Medable and Nebula Genomics. Broad incumbents are 23andMe and Verily (Alphabet). Direct peers are Tempus AI, Owkin, SOPHiA Genetics and DNAnexus. Avalanche (blockchain infrastructure) is listed as an others.

Does LIFE AI have an API?

No public API is recorded for LIFE AI.

What industry is LIFE AI in?

LIFE AI's product category is Healthcare AI Infrastructure. Its primary akta.pro industry code is HLAGAJAO, AI/ML Platforms for Drug Discovery & Experiment Optimization, with a secondary code of HLAGAJAD, Bioinformatics & Multi-omics Analysis Software. Its NAICS code is 51321 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Business InsiderKalbe Farma and LIFE AI Unveil StrokeGENME to Personalize Stroke Prevention at National ScaleKalbe Farma and LIFE AI launched StrokeGENME, a genetics-powered platform for personalized stroke prevention across Indonesia. The partnership reduces development costs by 10–30x, enabling broader access to clinician-guided programs for high-risk patients. Kalbe aims to expand the approach to additional chronic diseases.Vietnam Economic TimesGStar Summit 2026: Shaping the Future of Human-Centered Artificial Intelligence in the Asia-PacificGStar Summit 2026, a human-centered AI conference, was held on May 29, 2026, in Ho Chi Minh City, Vietnam, co-organized by the New Turing Institute and Pacific Gateway Partners, with Google and FPT as strategic partners and support from Vietnam Airlines, Grab, LIFE AI, Calif, Galaxy Holdings, and VNG. The summit attracted over 1,000 participants from more than 160 companies and institutions, featuring 20 world-class speakers including Google DeepMind, NVIDIA, Meta, and SK Group executives discussing agentic AI, education in the AI era, and AI applications across industries. The event marked Vietnam's growing strategic role in the Asia-Pacific AI landscape and reinforced the country's potential to accelerate AI capabilities to international standards.GlobeNewswireLIFE AI Builds Upon Global Biohub by Initiating Deployment of PREVANA Subnets in ThailandLIFE AI initiated nationwide deployment of its PREVANA subnet in Thailand, expanding its AI-native Biohub infrastructure for preventive healthcare. The deployment leverages the Volunteer Medical Association's network to reach communities at scale, aiming to validate operational performance and economic sustainability. Thailand serves as a proof point for global scalability.GlobeNewswireKalbe Farma and LIFE AI Unveil StrokeGENME to Personalize Stroke Prevention at National ScalePT Kalbe Farma Tbk, through its subsidiary Kalgen Innolab Clinical Laboratory, has partnered with LIFE AI to launch StrokeGENME, a genetics-powered platform that translates DNA insights into personalized stroke-prevention plans delivered through Kalbe's nationwide healthcare ecosystem in Indonesia. The platform aims to address rising stroke rates across all age groups by offering clinician-guided prevention programs, medication guidance, lifestyle solutions, and ongoing monitoring. Kalbe plans to expand this personalized-prevention approach to additional chronic diseases beyond stroke.The Manila TimesLIFE AI CEO Tuan Cao Named to Tatler Most Influential List 2025Dr. Tuan Cao, founder of LIFE AI, was named to the Tatler Most Influential List 2025 for Vietnam. The company's AI platform has accelerated healthcare product development, such as reducing a stroke prevention product's launch from 24 months to six weeks. Cao said LIFE AI will continue advancing life care with speed, scale, and innovation.GlobeNewswireLIFE AI CEO Tuan Cao Named to Tatler Most Influential List 2025LIFE AI CEO Tuan Cao was named to the Tatler Most Influential List 2025 for Vietnam. The company's AI platform has accelerated healthcare product development, such as reducing a 24-month cycle to six weeks. Cao said LIFE AI will continue advancing life care with speed, scale, and innovation.GlobeNewswireLIFE AI CEO Tuan Cao Named to Tatler Most Influential List 2025Dr. Tuan Cao, founder and CEO of LIFE AI, has been named to the Tatler Most Influential List 2025 for Vietnam, recognizing his contributions to AI-driven healthcare innovation. The article highlights LIFE AI's achievements including conducting Southeast Asia's largest autism genetic study for $10,000 and helping Kalbe Farma launch a personalized stroke prevention product in six weeks instead of the typical 24-month development cycle. LIFE AI, a Singapore-based AI platform company, is operating a foundational AI platform enabling businesses to launch life science products from idea-to-market faster and at reduced cost.GlobeNewswireLIFE AI Joins First Ever FastTrack AI Accelerator Powered By GenAI Fund and NVIDIA Inception ProgramLIFE AI was selected to join the first-ever FastTrack AI Accelerator Cohort 1, powered by GenAI Fund and NVIDIA, after being chosen from over 300 applicants. The Singapore-based company, which has powered precision health for over 100,000 users, will receive up to $1M in compute and technical support over 12 weeks. It plans to transition to an AI-first Model-as-a-Service strategy.GlobeNewswireLIFE AI Joins First Ever FastTrack AI Accelerator Powered By GenAI Fund and NVIDIA Inception ProgramLIFE AI has been selected for the inaugural cohort of the FastTrack AI Accelerator, a program powered by GenAI Fund and NVIDIA. The 12-week initiative will provide the Singapore-based company with up to $1 million in compute power, technical support, and investment opportunities to accelerate its transition to an AI-first business model. This selection follows LIFE AI's track record of reducing healthcare product development cycles significantly through its precision health platform.